Industry News
Pharmaceutical Industry News
Growing Cannabis and Opium Poppies May Be Key to U.S. Supply Chains
After supply chain disruptions that made critical medicines scarce, a federal effort is underway to ensure domestic stocks of pharmaceutical ingredients.
Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded versions of the medications.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
International Ring Sent Fake Fentanyl and Other Deadly Pills From NYC, US Says
The drugs, which resembled real pharmaceuticals, killed nine people, prosecutors said. They were laced with fentanyl and methamphetamine.
Biden Officials Stave Off Sticker Shock on Medicare Drug Premiums
Federal regulators spent billions of dollars to avoid a spike in costs for older Americans that could have been politically damaging to the presidential campaign of Vice President Kamala Harris.
F.D.A. Approves a New Antipsychotic Drug
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
The Global Threat of Antibiotic Resistance
Health experts, gathering at the U.N., have begun to shift their focus to try to provide access to basic drugs in countries where preventable deaths from infections occur too frequently.
Qué es la rapamicina y por qué se piensa que sirve para mantenerse joven
La rapamicina se suele recetar como inmunosupresor, pero hay quienes creen que puede hacer mucho más.
Rapamycin and Anti-Aging: What to Know
Rapamycin is typically prescribed as an immunosuppressive, but off-label users believe it can do much more.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Nasal Flu Vaccine Is Approved for At-Home Use
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
Francis Collins: Take It From a Scientist. Facts Matter, and They Don’t Care How You Feel.
I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.
John A. Clements Dies at 101; His Research Saved Thousands of Babies
He identified the cause of a respiratory condition that was killing 10,000 infants a year in the United States. Then he helped design a drug that slashed those mortality rates.
Is Obesity a Disease? It’s Complicated in the Age of Ozempic.
Experts are rushing to redefine obesity amid soaring demand for new weight loss drugs.
Kourtney Kardashian’s Weight Loss Supplement Claims to Work Like Ozempic. Does It?
Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.
First Day of a ‘New Life’ for a Boy With Sickle Cell
Kendric Cromer, 12, is among the first patients to be treated with gene therapy just approved by the F.D.A. that many other patients face obstacles to receiving.
El ‘médico rural’ que transformó nuestra manera de ver la demencia
Francisco Lopera desafió rebeldes, carteles y murciélagos vampiro para convertirse en un investigador pionero del alzhéimer.
The Campaign Issue That Isn’t: Health Care Reform
The topic has been a major concern in presidential elections for decades. Its absence as a top issue now is notable.
Adderall, Vyvanse in Higher Doses May Be Tied to Psychosis Risk, Study Says
New research suggests that dosage plays a role in a rare side effect of A.D.H.D. stimulants.